Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Arthritis, Rheumatoid × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 5 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Colorectal Neoplasms 3 Gastrointestinal Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Resectable 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Arthritis, Rheumatoid 1 Anatomic Stage I Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1

Interventions

Methotrexate 7 Etanercept 5 Adalimumab 5 tocilizumab 4 Rituximab 4 tofacitinib 3 Abatacept 3 golimumab 2 Tumor Necrosis Factor Inhibitors 2 Antirheumatic Agents 2 upadacitinib 1 secukinumab 1 sarilumab 1 olokizumab 1 mavrilimumab 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 Syringes 1 Sulfasalazine 1 Saline Solution 1 Leflunomide 1 Hydroxychloroquine 1 Herpes Zoster Vaccine 1 Folic Acid 1 Fish Oils 1 Fatty Acids, Omega-3 1 Eicosapentaenoic Acid 1 Double-Blind Method 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡